Compound Profiles
AHK-Cu
Hair Growth Copper Peptide | Dermal Papilla Stimulator
AHK-Cu penetrates scalp delivering copper directly to dermal papilla cells. Activates proliferation pathways, elevates Bcl-2/Bax ratio (anti-apoptotic), increases VEGF for blood flow, reduces TGF-β1, and promotes SOD production for oxidative stress reduction.
Tesamorelin
GHRH Analog | Visceral Fat Reduction
Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..
Combined Organ Load
Frequently Asked Questions
Can I take AHK-Cu with Tesamorelin?
Yes, AHK-Cu and Tesamorelin can generally be taken together. AHK-Cu and Tesamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Is AHK-Cu and Tesamorelin safe together?
Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between AHK-Cu and Tesamorelin?
AHK-Cu and Tesamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time AHK-Cu and Tesamorelin?
AHK-Cu has a half-life of Not established and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.